140 related articles for article (PubMed ID: 12506456)
21. Effective executive management in the pharmaceutical industry.
Tran H; Kleiner BH
J Health Care Finance; 2005; 32(1):8-15. PubMed ID: 18972973
[TBL] [Abstract][Full Text] [Related]
22. Little teddy bear brings big results to asthma DM program.
Healthc Demand Dis Manag; 1997 Jul; 3(7):110-2. PubMed ID: 10174910
[TBL] [Abstract][Full Text] [Related]
23. [Multiple sclerosis--a challenge for physician and patient].
Krankenpfl J; 2004; 42(5-6):181. PubMed ID: 15527241
[No Abstract] [Full Text] [Related]
24. Schizophrenia, drug companies and the internet.
Read J
Soc Sci Med; 2008 Jan; 66(1):99-109. PubMed ID: 17826878
[TBL] [Abstract][Full Text] [Related]
25. Multiple sclerosis disease-modifying therapies: adverse effect surveillance and management.
Wingerchuk DM
Expert Rev Neurother; 2006 Mar; 6(3):333-46. PubMed ID: 16533138
[TBL] [Abstract][Full Text] [Related]
26. [Proposals to improve adherence to immunomodulatory therapies in patients with multiple sclerosis].
Arroyo E; González M; Grau C; Arnal C; Bujanda M; de Castro P; Grau L; Martínez M; Ramo C; Sánchez V; Sánchez-Soliño O
Neurologia; 2010; 25(9):544-51. PubMed ID: 21093703
[TBL] [Abstract][Full Text] [Related]
27. Drug companies seek MS patients to lobby for new products.
Yamey G
BMJ; 2000 Jan; 320(7229):207. PubMed ID: 10642222
[No Abstract] [Full Text] [Related]
28. Disease management on the Web.
Sherter AL
Health Data Manag; 1998 Oct; 6(10):34, 36, 38. PubMed ID: 10185882
[No Abstract] [Full Text] [Related]
29. Industry support of graduate medical education in surgery.
Nakayama DK; Bozeman AP
Am Surg; 2009 May; 75(5):395-400. PubMed ID: 19445290
[TBL] [Abstract][Full Text] [Related]
30. Mixed messages on tobacco: comparative exposure to public health, tobacco company- and pharmaceutical company-sponsored tobacco-related television campaigns in the United States, 1999-2003.
Wakefield M; Szczypka G; Terry-McElrath Y; Emery S; Flay B; Chaloupka F; Saffer H
Addiction; 2005 Dec; 100(12):1875-83. PubMed ID: 16367989
[TBL] [Abstract][Full Text] [Related]
31. New Web-based program gets patients primed for DM.
Dis Manag Advis; 2006 Mar; 12(3):30-3, 25. PubMed ID: 16634377
[TBL] [Abstract][Full Text] [Related]
32. COPD gaining favor as focus for DM initiatives.
Dis Manag Advis; 2003 Apr; 9(4):49-54. PubMed ID: 12751141
[No Abstract] [Full Text] [Related]
33. Prescription drug advertising: is it a driving force on drug pricing?
Millstein LG
N C Med J; 2003; 64(6):289-91. PubMed ID: 14983621
[TBL] [Abstract][Full Text] [Related]
34. [Contact and dialogue between drug companies and the global regulatory authorities throughout research and development phase].
Kock M; Thomsen MK
Ugeskr Laeger; 2003 Apr; 165(16):1649-52. PubMed ID: 12756820
[TBL] [Abstract][Full Text] [Related]
35. Clinical guidelines: strategies to nurture acceptance and adherence.
Dis Manag Advis; 2003 Oct; 9(10):134-7, 129. PubMed ID: 14679872
[TBL] [Abstract][Full Text] [Related]
36. Diabetes demo project puts pharmacists in DM driver's seat.
Dis Manag Advis; 2003 Mar; 9(3):37-9, 33. PubMed ID: 12701448
[TBL] [Abstract][Full Text] [Related]
37. Why the MS patient needs your help.
Swift N
Nursing; 1979 Sep; 9(9):57-61. PubMed ID: 257223
[No Abstract] [Full Text] [Related]
38. New depression programs are designed with the employer in mind.
Dis Manag Advis; 2005 Jun; 11(6):65-9, 61. PubMed ID: 16060295
[TBL] [Abstract][Full Text] [Related]
39. Pfizer touts Medicaid data in arguing that DM works.
Carroll J
Manag Care; 2004 Dec; 13(12):8, 10. PubMed ID: 15656119
[No Abstract] [Full Text] [Related]
40. Pharmaceutical new product development: the increasing role of in-licensing.
Edwards NV
Anesthesiol Clin; 2008 Dec; 26(4):627-36, v. PubMed ID: 19041620
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
